Omega Diagnostics Group Plc (ODX):企業の製品パイプライン分析

◆英語タイトル:Omega Diagnostics Group Plc (ODX) - Product Pipeline Analysis, 2020 Update
◆商品コード:GDME207655PD
◆発行会社(調査会社):GlobalData
◆発行日:2021年1月
◆ページ数:35
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:イギリス
◆産業分野:Medical Devices
◆販売価格オプション(消費税別)
Site License(同一事業所内共有可)USD1,500 ⇒換算¥171,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD2,250 ⇒換算¥256,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Omega Diagnostics Group Plc (Omega) is a biotechnology company that provides in-vitro diagnostic products. The company offers products in the areas of allergy, food intolerance, autoimmune disease and infectious disease, among others. It also provides food intolerance and autoimmune tests for diseases such as renal disease, connective tissue disease and anaemia. Omega offers diagnosis of infectious diseases, including Syphilis, TB and Dengue Fever. The company supplies tests based on agglutination, enzyme immunoassay, fluorescence, rapid and micro-array technologies. It markets its diagnostic kits and systems to hospitals, blood banks, clinics and laboratories. The company operates in the UK, Germany and India. Omega is headquartered in Alva, the UK.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company Omega Diagnostics Group Plc
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to Buy:

- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
List of Tables
List of Figures
Omega Diagnostics Group Plc Company Overview
Omega Diagnostics Group Plc Company Snapshot
Omega Diagnostics Group Plc Pipeline Products and Ongoing Clinical Trials Overview
Omega Diagnostics Group Plc – Pipeline Analysis Overview
Omega Diagnostics Group Plc – Key Facts
Omega Diagnostics Group Plc – Major Products and Services
Omega Diagnostics Group Plc Pipeline Products by Development Stage
Omega Diagnostics Group Plc Pipeline Products Overview
FoodPrint Microarray 200+ Food IgG 16 pt
FoodPrint Microarray 200+ Food IgG 16 pt Product Overview
FoodPrint Microarray 200+ Food IgG 4 pt
FoodPrint Microarray 200+ Food IgG 4 pt Product Overview
FoodPrint Microarray 200+ Food IgG 64 pt
FoodPrint Microarray 200+ Food IgG 64 pt Product Overview
Point of Care Antibody Test – COVID-19
Point of Care Antibody Test – COVID-19 Product Overview
SmCTF-RDT
SmCTF-RDT Product Overview
Test Specific App – COVID-19
Test Specific App – COVID-19 Product Overview
VISITECT CD4 Advanced Disease Test – Malaria
VISITECT CD4 Advanced Disease Test – Malaria Product Overview
VISITECT CD4 Advanced Disease Test – Tubercuosis
VISITECT CD4 Advanced Disease Test – Tubercuosis Product Overview
Omega Diagnostics Group Plc – Key Competitors
Omega Diagnostics Group Plc – Key Employees
Omega Diagnostics Group Plc – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Recent Developments
Omega Diagnostics Group Plc, Recent Developments
Oct 06, 2020: Government invests in UK-developed antibody tests from UK Rapid Test Consortium
Dec 02, 2019: Omega Diagnostics Group: Interim results for the six months ended 30 September 2019
Dec 02, 2019: Omega Diagnostics Group: Nigerian order for VISITECT CD4
Oct 22, 2019: Omega Diagnostics Group: Trading update and notice of interim results to 30 September 2019
Sep 23, 2019: Omega diagnostics group: Final results for the year ended 31 march 2019
Mar 18, 2019: CE-Mark for VISITECT CD4 Advanced Disease test
Mar 06, 2019: Omega diagnostics provides update on VISITECT CD4
Mar 01, 2019: Omega diagnostics Group: Board appointment
Jan 29, 2019: Omega Diagnostics Group: VISITECT CD4 Advanced Disease test update
Dec 10, 2018: Omega Diagnostics Group: Directorate Change
Appendix
Methodology
About GlobalData
Contact Us
Disclaimer

List of Tables
Omega Diagnostics Group Plc Pipeline Products and Ongoing Clinical Trials Overview
Omega Diagnostics Group Plc Pipeline Products by Equipment Type
Omega Diagnostics Group Plc Pipeline Products by Indication
Omega Diagnostics Group Plc, Key Facts
Omega Diagnostics Group Plc, Major Products and Services
Omega Diagnostics Group Plc Number of Pipeline Products by Development Stage
Omega Diagnostics Group Plc Pipeline Products Summary by Development Stage
FoodPrint Microarray 200+ Food IgG 16 pt - Product Status
FoodPrint Microarray 200+ Food IgG 16 pt - Product Description
FoodPrint Microarray 200+ Food IgG 4 pt - Product Status
FoodPrint Microarray 200+ Food IgG 4 pt - Product Description
FoodPrint Microarray 200+ Food IgG 64 pt - Product Status
FoodPrint Microarray 200+ Food IgG 64 pt - Product Description
Point of Care Antibody Test - COVID-19 - Product Status
Point of Care Antibody Test - COVID-19 - Product Description
SmCTF-RDT - Product Status
SmCTF-RDT - Product Description
Test Specific App - COVID-19 - Product Status
Test Specific App - COVID-19 - Product Description
VISITECT CD4 Advanced Disease Test - Malaria - Product Status
VISITECT CD4 Advanced Disease Test - Malaria - Product Description
VISITECT CD4 Advanced Disease Test - Tubercuosis - Product Status
VISITECT CD4 Advanced Disease Test - Tubercuosis - Product Description
Omega Diagnostics Group Plc, Key Employees
Omega Diagnostics Group Plc, Other Locations
Omega Diagnostics Group Plc, Subsidiaries
Glossary

★海外企業調査レポート[Omega Diagnostics Group Plc (ODX):企業の製品パイプライン分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Proximus plc (PROX):企業の財務・戦略的SWOT分析
    Proximus plc (PROX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • Atnahs Pharma UK Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Atnahs Pharma UK Ltd (Atnahs Pharma), a subsidiary of Waymade Plc, is a developer, manufacturer, supplier and distributor of pharmaceutical products. The company provides products such as anacal ointment; dermacort cream; dipentum; gygel, a spermicidal contraceptive, and among others. Atnahs …
  • Pictet & Cie Group SCA:企業の戦略・SWOT・財務情報
    Pictet & Cie Group SCA - Strategy, SWOT and Corporate Finance Report Summary Pictet & Cie Group SCA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Kane Biotech Inc (KNE):企業の財務・戦略的SWOT分析
    Summary Kane Biotech Inc (Kane Biotech) is a biotechnology company which focuses on research, development and commercialization of novel products that prevent and remove biofilm related infections in humans and animals. The company’s products include StrixNB and Vetradent water additive, oral spray, …
  • Sihuan Pharmaceutical Holdings Group Ltd (460):企業の財務・戦略的SWOT分析
    Summary Sihuan Pharmaceutical Holdings Group Ltd (Sihuan Pharmaceutical) is a pharmaceutical company that develops, manufactures and markets prescription drugs. The company offers products in the therapeutic areas of cardio-cerebral vascular system, central nervous system, metabolism, oncology and a …
  • Bankinter Banca Privada:企業の戦略・SWOT・財務情報
    Bankinter Banca Privada - Strategy, SWOT and Corporate Finance Report Summary Bankinter Banca Privada - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Central Rand Gold Ltd:企業の戦略・SWOT・財務情報
    Central Rand Gold Ltd - Strategy, SWOT and Corporate Finance Report Summary Central Rand Gold Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Shearman & Sterling LLP:企業の戦略的SWOT分析
    Shearman & Sterling LLP - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products an …
  • Cyient Ltd (CYIENT):企業の財務・戦略的SWOT分析
    Cyient Ltd (CYIENT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • BOC Aviation Limited (2588):企業の財務・戦略的SWOT分析
    BOC Aviation Limited (2588) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • Merck & Co Inc (MRK)-医療機器分野:企業M&A・提携分析
    Summary Merck & Co Inc (Merck) focuses on the discovery, development, manufacture and commercialization of prescription pharmaceuticals, biologic therapies, vaccines and animal healthcare products. It offers prescription products for treating cardiovascular, cancer, immunology, infectious, respirato …
  • aap Implantate AG (AAQ):医療機器:M&Aディール及び事業提携情報
    Summary aap Implantate AG (aap Implantate) is a medical device company, which develops, manufactures and markets trauma products and biomaterials for orthopedic treatment. Its products include locked plating systems for anatomical reduction, cannulated screws, standard plates and screws for osteosyn …
  • C.A. Curtze Co. Inc.:企業の戦略・SWOT・財務分析
    C.A. Curtze Co. Inc. - Strategy, SWOT and Corporate Finance Report Summary C.A. Curtze Co. Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • MaxCyte Inc (MXCT):企業の財務・戦略的SWOT分析
    Summary MaxCyte Inc (MaxCyte) is a biotherapeutic company that conducts research and develops cell transfection technologies. The company offers MaxCyte STX, MaxCyte VLX and MaxCyte GT instruments. It utilizes flow electroporation technology for discovery, development and manufacturing of cell-based …
  • Vietnam Dairy Products Joint Stock Co:企業の戦略・SWOT・財務情報
    Vietnam Dairy Products Joint Stock Co - Strategy, SWOT and Corporate Finance Report Summary Vietnam Dairy Products Joint Stock Co - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analy …
  • ICICI Bank Ltd:企業の戦略・SWOT・財務情報
    ICICI Bank Ltd - Strategy, SWOT and Corporate Finance Report Summary ICICI Bank Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • EDF Renewable Energy Inc:電力:M&Aディール及び事業提携情報
    Summary EDF Renewable Energy, Inc. (EDF Renewable Energy), formerly, enXco, Inc., is an integrated energy company. It designs, develops, constructs and operates renewable energy projects in the biogas, biomass, hydro, solar, wind and marine energy sectors; and provides storage solutions. It develops …
  • Allied Hotel Properties Inc.:戦略・SWOT・企業財務分析
    Allied Hotel Properties Inc. - Strategy, SWOT and Corporate Finance Report Summary Allied Hotel Properties Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • AbbVie Inc (ABBV):医療機器:M&Aディール及び事業提携情報
    Summary AbbVie Inc (AbbVie) is a research-based biopharmaceutical company that develops, manufactures and commercializes advanced therapies for treating complex and serious diseases. It provides pharmaceutical drugs to treat conditions in rheumatology, gastroenterology, dermatology, oncology, virolo …
  • MOL Hungarian Oil and Gas PLC (MOL)-エネルギー分野:企業M&A・提携分析
    Summary MOL Hungarian Oil and Gas Public Limited Company (MOL) is an integrated oil and gas company. It explores develops and produces crude oil, natural gas. It conducts refining, transportation and storage of crude oil; wholesale and retail marketing of crude oil products, production and sale of p …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆